サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1720719

注意欠陥多動性障害の世界市場レポート 2025年

Attention Deficit Hyperactivity Disorder Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.28円
注意欠陥多動性障害の世界市場レポート 2025年
出版日: 2025年05月01日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

注意欠陥多動性障害市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.7％で225億9,000万米ドルに成長します。予測期間の成長は、治療を受ける小児および成人患者の増加、ヘルスケアインフラの強化、個別化医療の採用拡大、メンタルヘルス問題の受け入れ拡大、子どもの食事における添加物・保存料の使用増加などが牽引するとみられます。この期間の主な動向としては、技術の向上と革新的な治療法、診断・治療法の進歩、新しい治療薬の開発、非刺激性薬へのシフト、薬物治療の進歩などが挙げられます。

個別化医療の採用拡大が、今後数年間の注意欠陥多動性障害（ADHD）市場の成長を牽引すると予想されます。個別化医療とは、個人の遺伝的、環境的、ライフスタイル的要因に基づいて治療をカスタマイズするヘルスケアアプローチであり、より精密で効果的な治療につながります。個別化医療への関心が高まっている背景には、ゲノム技術の進歩があります。このアプローチは、個人の特性に対応したカスタマイズされた治療戦略を可能にすることで、ADHDの管理を大幅に強化し、より的を絞った効果的な介入につながります。例えば、2024年2月、個別化医療連合（Personalized Medicine Coalition）の報告書によると、2023年にFDAが承認した新薬の3分の1以上を個別化医薬品が占め、4年連続となったことが明らかになりました。FDAは、希少疾患の治療薬16品目、抗がん剤7品目、その他の治療薬3品目を新たに個別化治療薬として承認しました。その結果、個別化医療の採用拡大がADHD市場の拡大を後押ししています。

ADHD市場の各社は、有効性を向上させ、患者のコンプライアンスを強化し、症状を長期間抑制するために、徐放性錠剤などの革新的な治療法の開発に注力しています。これらの錠剤は薬物を徐々に放出するため、1回の服用で1日中一貫した症状のコントロールが可能です。これにより、複数回服用の必要性が減り、ADHD患者の利便性と治療計画の遵守が向上します。例えば、カナダに本社を置く製薬会社JAMP Pharma Groupは2022年2月、武田カナダ社のINTUNIV XRのジェネリック医薬品であるGuanfacine XRを発売しました。Guanfacine XRは、脳内の受容体を標的として、注意力、衝動制御、多動性を改善する長時間作用型の薬剤です。様々な強さ（1mg、2mg、3mg、4mg）があり、100錠入りであるため、柔軟な治療が可能です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界注意欠陥多動性障害 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界の注意欠陥多動性障害市場：成長率分析
  • 世界の注意欠陥多動性障害市場の実績：規模と成長, 2019-2024
  • 世界の注意欠陥多動性障害市場の予測：規模と成長, 2024-2029, 2034F
  • 世界注意欠陥多動性障害総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の注意欠陥多動性障害市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 覚醒剤
  • 非刺激剤
  • 世界の注意欠陥多動性障害市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 子供たち
  • 大人
  • 世界の注意欠陥多動性障害市場性別：、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 男
  • 女性
  • 世界の注意欠陥多動性障害市場剤形別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • タブレット
  • カプセル
  • その他の剤形
  • 世界の注意欠陥多動性障害市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 小売薬局
  • 病院薬局
  • オンライン薬局
  • 世界の注意欠陥多動性障害市場、覚醒剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • メチルフェニデート系薬剤
  • アンフェタミン系薬剤
  • 混合アンフェタミン塩
  • デキスメチルフェニデート
  • 世界の注意欠陥多動性障害市場非刺激薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • アトモキセチン（ストラテラ）
  • グアンファシン（インチュニブ）
  • クロニジン（カプベイ）
  • ブプロピオン（ウェルブトリン）

第7章 地域別・国別分析

  • 世界の注意欠陥多動性障害市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の注意欠陥多動性障害市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 注意欠陥多動性障害市場：競合情勢
  • 注意欠陥多動性障害市場：企業プロファイル
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
    • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
    • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Eli Lilly and Company
  • Teva Pharmaceutical Industries Ltd.
  • Otsuka Pharmaceutical Co. Ltd.
  • Supernus Pharmaceuticals Inc.
  • Neos Therapeutics Inc.
  • Collegium Pharmaceutical Inc.
  • Mallinckrodt Pharmaceuticals plc
  • Tris Pharma Inc.
  • Arbor Pharmaceuticals LLC
  • Akili Interactive Labs Inc.
  • Mind Medicine（MindMed）Inc.
  • NeuroSigma Inc.
  • KemPharm Inc.
  • RespireRx Pharmaceuticals Inc.
  • Cingulate Therapeutics LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 注意欠陥多動性障害市場2029：新たな機会を提供する国
  • 注意欠陥多動性障害市場2029：新たな機会を提供するセグメント
  • 注意欠陥多動性障害市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r33974

Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental condition marked by persistent inattention, hyperactivity, and impulsivity that disrupt daily functioning. It typically starts in childhood and may continue into adulthood, affecting focus, self-control, and organizational skills. Treatment options include behavioral therapy, medication, and lifestyle changes.

The primary types of ADHD treatment are stimulants and non-stimulants. Stimulants are medications that increase brain activity to improve focus, attention, and impulse control, and are commonly used for managing ADHD. ADHD treatments are categorized by age (children and adults) and gender (male and female). ADHD medications come in various forms, including tablets, capsules, and others, and are distributed through multiple channels such as retail pharmacies, hospital pharmacies, and online pharmacies.

The attention deficit hyperactivity disorder market research report is one of a series of new reports from The Business Research Company that provides attention deficit hyperactivity disorder market statistics, including the attention deficit hyperactivity disorder industry global market size, regional shares, competitors with the attention deficit hyperactivity disorder market share, detailed attention deficit hyperactivity disorder market segments, market trends, and opportunities, and any further data you may need to thrive in the attention deficit hyperactivity disorder industry. This attention deficit hyperactivity disorder market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The attention deficit hyperactivity disorder market size has grown strongly in recent years. It will grow from $16.29 billion in 2024 to $17.43 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth during the historic period can be attributed to the rising prevalence of ADHD, the increasing incidence of ADHD in children, growing awareness of the condition, higher healthcare expenditure, and government initiatives focused on mental health awareness.

The attention deficit hyperactivity disorder market size is expected to see strong growth in the next few years. It will grow to $22.59 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period is expected to be driven by an increasing number of pediatric and adult patients receiving treatment, enhanced healthcare infrastructure, a growing adoption of personalized medicine, greater acceptance of mental health issues, and the rising use of additives and preservatives in children's diets. Key trends during this period include improvements in technology and innovative treatments, advancements in diagnostic and treatment methods, the development of new therapeutic agents, a shift towards non-stimulant medications, and progress in pharmaceutical treatments.

The increasing adoption of personalized medicine is expected to drive the growth of the attention deficit hyperactivity disorder (ADHD) market in the coming years. Personalized medicine is a healthcare approach that customizes treatments based on an individual's genetic, environmental, and lifestyle factors, leading to more precise and effective therapies. The growing interest in personalized medicine can be attributed to advancements in genomic technologies, which allow treatments to be tailored to a person's genetic profile. This approach significantly enhances the management of ADHD by enabling customized treatment strategies that address an individual's unique characteristics, leading to more targeted and effective interventions. For example, in February 2024, a report from the Personalized Medicine Coalition revealed that personalized medicines accounted for over a third of new FDA drug approvals in 2023, marking the fourth consecutive year. The FDA approved 16 new personalized treatments for rare diseases, 7 cancer drugs, and 3 other treatments. As a result, the growing adoption of personalized medicine is driving the expansion of the ADHD market.

Companies in the ADHD market are focusing on developing innovative treatments such as extended-release tablets to improve efficacy, enhance patient compliance, and provide long-lasting symptom control. These tablets release medication gradually, providing consistent control of symptoms throughout the day with a single dose. This reduces the need for multiple doses, improving convenience and adherence to the treatment plan for individuals with ADHD. For instance, in February 2022, JAMP Pharma Group, a pharmaceutical company based in Canada, launched Guanfacine XR, a generic version of Takeda Canada Inc.'s INTUNIV XR. Guanfacine XR is a long-acting medication that targets receptors in the brain to improve attention, impulse control, and hyperactivity. Available in various strengths (1 mg, 2 mg, 3 mg, and 4 mg) and packaged in 100-count bottles, the drug offers flexibility in treatment.

In September 2024, Collegium Pharmaceutical Inc., a US-based specialty pharmaceutical company, acquired Ironshore Therapeutics Inc. for $525 million. This acquisition is part of Collegium's strategy to expand its portfolio beyond pain management and strengthen its presence in the growing ADHD market, particularly with its differentiated ADHD product, Jornay PM. Ironshore Therapeutics, also based in the US, focuses on developing and commercializing therapies for ADHD.

Major players in the attention deficit hyperactivity disorder market are Pfizer Inc., Johnson & Johnson, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Supernus Pharmaceuticals Inc., Neos Therapeutics Inc., Collegium Pharmaceutical Inc., Mallinckrodt Pharmaceuticals plc, Tris Pharma Inc., Arbor Pharmaceuticals LLC, Akili Interactive Labs Inc., Mind Medicine (MindMed) Inc., NeuroSigma Inc., KemPharm Inc., RespireRx Pharmaceuticals Inc., Cingulate Therapeutics LLC, and Adlon Therapeutics L.P.

North America was the largest region in the attention deficit hyperactivity disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in attention deficit hyperactivity disorder report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the attention deficit hyperactivity disorder market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The attention deficit hyperactivity disorder market consists of revenues earned by entities by providing services such as diagnosis, therapy, counselling, medication management, and digital health solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The attention deficit hyperactivity disorder (ADHD) market also includes sales of medical devices, digital therapeutics, and assistive learning tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Attention Deficit Hyperactivity Disorder Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on attention deficit hyperactivity disorder market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for attention deficit hyperactivity disorder ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The attention deficit hyperactivity disorder market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Stimulants; Non-Stimulants
  • 2) By Age Group: Children; Adults
  • 3) By Gender: Male; Female
  • 4) By Dosage Form: Tablets; Capsules; Other Dosage Forms
  • 5) By Distribution Channel: Retail Pharmacy; Hospital Pharmacy; Online Pharmacy
  • Subsegments:
  • 1) By Stimulants: Methylphenidate-based Medications; Amphetamine-based Medications; Mixed Amphetamine Salts; Dexmethylphenidate
  • 2) By Non-Stimulants: Atomoxetine (Strattera); Guanfacine (Intuniv); Clonidine (Kapvay); Bupropion (Wellbutrin)
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AstraZeneca PLC; Novartis International AG; Takeda Pharmaceutical Company Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Attention Deficit Hyperactivity Disorder Market Characteristics

3. Attention Deficit Hyperactivity Disorder Market Trends And Strategies

4. Attention Deficit Hyperactivity Disorder Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Attention Deficit Hyperactivity Disorder Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Attention Deficit Hyperactivity Disorder PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Attention Deficit Hyperactivity Disorder Market Growth Rate Analysis
  • 5.4. Global Attention Deficit Hyperactivity Disorder Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Attention Deficit Hyperactivity Disorder Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Attention Deficit Hyperactivity Disorder Total Addressable Market (TAM)

6. Attention Deficit Hyperactivity Disorder Market Segmentation

  • 6.1. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stimulants
  • Non-Stimulants
  • 6.2. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Children
  • Adults
  • 6.3. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Male
  • Female
  • 6.4. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tablets
  • Capsules
  • Other Dosage Forms
  • 6.5. Global Attention Deficit Hyperactivity Disorder Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
  • 6.6. Global Attention Deficit Hyperactivity Disorder Market, Sub-Segmentation Of Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Methylphenidate-based Medications
  • Amphetamine-based Medications
  • Mixed Amphetamine Salts
  • Dexmethylphenidate
  • 6.7. Global Attention Deficit Hyperactivity Disorder Market, Sub-Segmentation Of Non-Stimulants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Atomoxetine (Strattera)
  • Guanfacine (Intuniv)
  • Clonidine (Kapvay)
  • Bupropion (Wellbutrin)

7. Attention Deficit Hyperactivity Disorder Market Regional And Country Analysis

  • 7.1. Global Attention Deficit Hyperactivity Disorder Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Attention Deficit Hyperactivity Disorder Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Attention Deficit Hyperactivity Disorder Market

  • 8.1. Asia-Pacific Attention Deficit Hyperactivity Disorder Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Attention Deficit Hyperactivity Disorder Market

  • 9.1. China Attention Deficit Hyperactivity Disorder Market Overview
  • 9.2. China Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Attention Deficit Hyperactivity Disorder Market

  • 10.1. India Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Attention Deficit Hyperactivity Disorder Market

  • 11.1. Japan Attention Deficit Hyperactivity Disorder Market Overview
  • 11.2. Japan Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Attention Deficit Hyperactivity Disorder Market

  • 12.1. Australia Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Attention Deficit Hyperactivity Disorder Market

  • 13.1. Indonesia Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Attention Deficit Hyperactivity Disorder Market

  • 14.1. South Korea Attention Deficit Hyperactivity Disorder Market Overview
  • 14.2. South Korea Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Attention Deficit Hyperactivity Disorder Market

  • 15.1. Western Europe Attention Deficit Hyperactivity Disorder Market Overview
  • 15.2. Western Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Attention Deficit Hyperactivity Disorder Market

  • 16.1. UK Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Attention Deficit Hyperactivity Disorder Market

  • 17.1. Germany Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Attention Deficit Hyperactivity Disorder Market

  • 18.1. France Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Attention Deficit Hyperactivity Disorder Market

  • 19.1. Italy Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Attention Deficit Hyperactivity Disorder Market

  • 20.1. Spain Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Attention Deficit Hyperactivity Disorder Market

  • 21.1. Eastern Europe Attention Deficit Hyperactivity Disorder Market Overview
  • 21.2. Eastern Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Attention Deficit Hyperactivity Disorder Market

  • 22.1. Russia Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Attention Deficit Hyperactivity Disorder Market

  • 23.1. North America Attention Deficit Hyperactivity Disorder Market Overview
  • 23.2. North America Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Attention Deficit Hyperactivity Disorder Market

  • 24.1. USA Attention Deficit Hyperactivity Disorder Market Overview
  • 24.2. USA Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Attention Deficit Hyperactivity Disorder Market

  • 25.1. Canada Attention Deficit Hyperactivity Disorder Market Overview
  • 25.2. Canada Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Attention Deficit Hyperactivity Disorder Market

  • 26.1. South America Attention Deficit Hyperactivity Disorder Market Overview
  • 26.2. South America Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Attention Deficit Hyperactivity Disorder Market

  • 27.1. Brazil Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Attention Deficit Hyperactivity Disorder Market

  • 28.1. Middle East Attention Deficit Hyperactivity Disorder Market Overview
  • 28.2. Middle East Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Attention Deficit Hyperactivity Disorder Market

  • 29.1. Africa Attention Deficit Hyperactivity Disorder Market Overview
  • 29.2. Africa Attention Deficit Hyperactivity Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Attention Deficit Hyperactivity Disorder Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Attention Deficit Hyperactivity Disorder Market, Segmentation By Gender, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Attention Deficit Hyperactivity Disorder Market Competitive Landscape And Company Profiles

  • 30.1. Attention Deficit Hyperactivity Disorder Market Competitive Landscape
  • 30.2. Attention Deficit Hyperactivity Disorder Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Attention Deficit Hyperactivity Disorder Market Other Major And Innovative Companies

  • 31.1. Eli Lilly and Company
  • 31.2. Teva Pharmaceutical Industries Ltd.
  • 31.3. Otsuka Pharmaceutical Co. Ltd.
  • 31.4. Supernus Pharmaceuticals Inc.
  • 31.5. Neos Therapeutics Inc.
  • 31.6. Collegium Pharmaceutical Inc.
  • 31.7. Mallinckrodt Pharmaceuticals plc
  • 31.8. Tris Pharma Inc.
  • 31.9. Arbor Pharmaceuticals LLC
  • 31.10. Akili Interactive Labs Inc.
  • 31.11. Mind Medicine (MindMed) Inc.
  • 31.12. NeuroSigma Inc.
  • 31.13. KemPharm Inc.
  • 31.14. RespireRx Pharmaceuticals Inc.
  • 31.15. Cingulate Therapeutics LLC

32. Global Attention Deficit Hyperactivity Disorder Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Attention Deficit Hyperactivity Disorder Market

34. Recent Developments In The Attention Deficit Hyperactivity Disorder Market

35. Attention Deficit Hyperactivity Disorder Market High Potential Countries, Segments and Strategies

  • 35.1 Attention Deficit Hyperactivity Disorder Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Attention Deficit Hyperactivity Disorder Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Attention Deficit Hyperactivity Disorder Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer